Moderna (MRNA) Non Operating Income (2018 - 2026)
Moderna (MRNA) reported Non Operating Income of -$18.0 million for Q1 2026, down 350.0% year-over-year from $7.2 million in Q1 2025, and down 50.0% quarter-over-quarter from -$12.0 million in Q4 2025.
Moderna (MRNA) Non Operating Income (2018 - 2026) Analysis & Trends
Moderna (MRNA) has 9 years of Non Operating Income data on file, last reported at -$18.0 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$18.0 million, down 350.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.0 million (up 69.44% YoY), and the FY2025 annual result was -$8.0 million, up 90.8% from the prior year.
- Non Operating Income eased to -$18.0 million in Q1 2026 per MRNA's latest filing, from -$12.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at $14.0 million in Q2 2023 and troughed at -$51.0 million in Q3 2023.
- A 5-year average of -$17.6 million and a median of -$13.0 million in 2022 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 207.69% in 2023 and fell as far as 628.57% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$12.0 million in 2022, then plunged by 225.0% to -$39.0 million in 2023, then grew by 25.64% to -$29.0 million in 2024, then soared by 58.62% to -$12.0 million in 2025, then sank by 50.0% to -$18.0 million in 2026.
- Business Quant data shows MRNA's Non Operating Income at -$18.0 million in Q1 2026, -$12.0 million in Q4 2025, and $8.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | -18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.00 Mn |
| Dec 31, 2025 | -12.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | -4.00 Mn |
| Dec 31, 2024 | -29.00 Mn |
| Sep 30, 2024 | -12.00 Mn |
| Jun 30, 2024 | -27.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Dec 31, 2023 | -39.00 Mn |
| Sep 30, 2023 | -51.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | -48.00 Mn |
| Dec 31, 2022 | -12.00 Mn |
| Sep 30, 2022 | -7.00 Mn |
| Jun 30, 2022 | -13.00 Mn |
| Mar 31, 2022 | -13.00 Mn |
| Dec 31, 2021 | -7.00 Mn |
| Sep 30, 2021 | -10.00 Mn |
| Jun 30, 2021 | -2.00 Mn |
| Mar 31, 2021 | -10.00 Mn |